252 research outputs found

    Hematological, biochemical and microbiological evaluation of feline whole blood units collected using an open system and stored for 35 days

    Get PDF
    Despite the increasing availability of feline blood, which is collected and stored for transfusion purposes, few studies have assessed the effect of storage on feline whole blood (WB) units. The purpose of this study was to investigate selected hematologic and biochemical changes during storage of feline WB units and to determine when they occurred. Data from a quality control program for WB units was used in this study. Twelve feline WB units, collected using an open system, were sampled every 7 days from the point of collection to the end of storage at 35 days (D0, D7, D14, D21, D28, and D35). Measurements at each time point were: (1) hematologic parameters; (2) percentage hemolysis; (3) morphologic index scored at 0\u20133, based on echinocyte transformation of the erythrocytes; and (4) selected biochemical parameters. Aerobic and anaerobic culture was performed at D0 and D35. Results were compared statistically to D0 (statistical significance set at <0.01). Storage did not result in statistically significant changes in measured hematological parameters. There were statistically significant increases in percentage hemolysis and morphologic index, starting from D21 (P = 0.000 and P = 0.004, respectively). Glucose decreased significantly from D21 (P = 0.003); potassium increased significantly from D7 (P=0.001); and sodium increased significantly, starting from D28 (P = 0.009). Bacteria were not isolated. Blood in feline WB units collected using an open system underwent some significant storage changes that were time-dependent. As these changes could affect the quality and the utility of stored WB used in feline transfusion medicine, further study is required to determine their clinical importance

    Evaluation of Feline Packed Red Blood Cell Units Obtained by Blood Sedimentation and Stored for 42 Days for Transfusion Purposes

    Get PDF
    Component therapy involves separation of whole blood (WB) into its components (packed red blood cells\u2014PRBCs\u2014and plasma), for specific replacement therapy and to reduce transfusion reactions. In cats, blood for transfusion is commonly collected using an open system and administered as WB, in part because of the challenge of preparing components from a small blood volume. Feline blood has a high erythrocyte sedimentation rate; therefore, if the syringe containing collected blood is placed upright, plasma can be removed from the red cells shortly after collection for separate storage of plasma and PRBCs. The aim of this study was to assess the characteristics of feline PRBC units obtained by blood sedimentation both at collection and after storage for 42 days. Blood was collected from fourteen feline blood donors into three 20-ml syringes pre-charged with CPDA-1:blood ratio of 1:7 using an open system. A pre-donation CBC was performed in each donor. The three syringes were allowed to sediment for approx. 1 hour at room temperature. Then plasma was aseptically expressed into plain transfer bags and RBC expressed into another transfer bag pre-charged with 10 ml of SAG-M. PRBCs units were stored in a blood-dedicated refrigerator and sampled using blood bag segments at preparation time (D0) and after 42 days storage (D42). On pre-donation blood and on PRBC units at D0 and D42 the following parameters were evaluated: I) hematological parameters (RBC, Hb, Hct, WBC, PLT); II) percentage hemolysis; III) morphological index (only for PRBC units), scored of 0 to 3 based on echinocyte transformation of the normal discocyte; IV) aerobic and anaerobic blood culture (only for PRBC units). From donor to PRBC units there was a significant increase in RBC count (mean increase +1886\ub1SD1399 \u3bcL/103), Hb concentration (+2.8\ub12.2 g/dl), Hct percentage (+8.3\ub15.5%). Significant reduction was found in PLT count (-249\ub1189 \u3bcL/103). Comparing PRBC at D0 and D42 a significant increase was found in percentage hemolysis (+1.2%), morphological index (+0.9) and a significant reduction in RBC count (-460\ub1679 \u3bcL/103), Hct percentage (-3.2\ub13.5%), WBC count (median -2589 \u3bcL/103), and PLT count (median -43 \u3bcL/10). All blood cultures were negative for bacterial growth. PRBC units obtained by sedimentation of donated blood appear to be a suitable blood component for treatment of normovolemic anemia. However, storage for 42 days, as suggested for canine and feline PRBC units, resulted in significant hematological changes that could reduce oxygen delivery after transfusion

    Evaluation of feline red blood cells collected with an open system and stored for 35 days as whole blood units

    Get PDF
    Introduction: The increasing access to veterinary hospital blood banks and commercial sources of feline blood products means that transfusion therapy is more widely available to veterinarians and feline stored blood products are used more often. Despite the increasing availability of feline blood collected and stored for transfusion purposes, few studies have investigated storage lesions in feline whole blood (FWB) units and no study has evaluated hematological changes in FWB units. The objective of this study was to assess changes in feline RBCs collected and stored for transfusion purposes as FWB units. Methods:A prospective, laboratory invitrostudy wasconducted. Twelve nonleukoreduced FWB units were collected with an open system using three 20-mL syringes prefilled with citrate, phos- phate, dextrose, and adenine (CPDA-1) preservative-anticoagulant solution with ratio with blood of 1:7 from anesthetized feline blood donors. Units were stored in a blood bank dedicated refrigerator and sampled every 7 days (D7, D14, D21, D28) from collection (D0) to the end of storage (35 days, D35). At each time point, the following were evaluated: (1) hematological parameters (RBC, HGB, HCT, MCV, MCH, MCHC, RDW); (2) percentage of hemolysis; (3) morphological index, scored of 0 to 4 based on echinocyte transformation of the normal discocyte; and (4) aerobic and anaerobic blood culture. Results were statistically compared to D0, with t-test or Wilcoxon test, as appropriate with statistical significance set at P < 0.01. Results: There was no significant difference in hematological parameters at any time point with respect to D0. Significant increases were found in percentage of hemolysis and morphological index starting from 21 days of storage (P = 0.0002 and P = 0.0039, respectively). Mean hemolysis percentage value was less than 1% up to 21 days of storage. All blood cultures were negative for bacterial growth. Conclusion: RBCs in FWB units collected with an open system can undergo some significant hematological changes, but these results suggest that storage for up to 21 days is safe. In vivo studies are required to establish if these changes affect the ability of stored RBCs to circulate and provide adequate oxygen delivery after transfusion

    Ten years of lateral flow immunoassay technique applications: Trends, challenges and future perspectives

    Get PDF
    The Lateral Flow Immunoassay (LFIA) is by far one of the most successful analytical platforms to perform the on-site detection of target substances. LFIA can be considered as a sort of lab-in-a-hand and, together with other point-of-need tests, has represented a paradigm shift from sample-to-lab to lab-to-sample aiming to improve decision making and turnaround time. The features of LFIAs made them a very attractive tool in clinical diagnostic where they can improve patient care by enabling more prompt diagnosis and treatment decisions. The rapidity, simplicity, relative cost-effectiveness, and the possibility to be used by nonskilled personnel contributed to the wide acceptance of LFIAs. As a consequence, from the detection of molecules, organisms, and (bio)markers for clinical purposes, the LFIA application has been rapidly extended to other fields, including food and feed safety, veterinary medicine, environmental control, and many others. This review aims to provide readers with a 10-years overview of applications, outlining the trends for the main application fields and the relative compounded annual growth rates. Moreover, future perspectives and challenges are discussed

    NanoMIP-based solid phase extraction of fluoroquinolones from human urine: A proof-of-concept study

    Get PDF
    NanoMIPs that are prepared by solid phase synthesis have proven to be very versatile, but to date only limited attention has been paid to their use in solid phase extraction. Thus, since nanoMIPs show close similarities, in terms of binding behavior, to antibodies, it seems relevant to verify if it is possible to use them as mimics of the natural antibodies that are used in immunoextraction methods. As a proof-of-concept, we considered prepared nanoMIPs against fluoroquinolone ciprofloxacin. Several nanoMIPs were prepared in water with polymerization mixtures of different compositions. The polymer with the highest affinity towards ciprofloxacin was then grafted onto a solid support and used to set up a solid phase extraction–HPLC method with fluorescence detection, for the determination of fluoroquinolones in human urine. The method resulted in successful selection for the fluoroquinolone antibiotics, such that the nanoMIPs were suitable for direct extraction of the antibiotics from the urine samples at the µg mL−1 level. They required no preliminary treatment, except for a 1 + 9 (v/v) dilution with a buffer of pH 4.5 and they had good analyte recovery rates; up to 85% with precision in the range of 3 to 4.5%, without interference from the matrix. These experimental results demonstrate, for the first time, the feasibility of the use of nanoMIPs to develop solid phase extraction methods

    Prevalence of Ca Blood Type and Alloantibodies in a Population of Horses from Italy

    Get PDF
    A knowledge of the blood groups and alloantibodies present is essential for the safe transfusion of blood products in horses. Pre-transfusion screening and blood typing minimizes the risk of incompatible RBC transfusions and prevents immunization of the recipient against incompatible RBC antigens. The frequencies of blood groups can vary among different breeds. Knowledge of a breed's blood group prevalence can be very useful for identifying the best blood donors during transfusion in clinical practice. The aims of this study were to estimate the prevalence of the Ca blood type in horses from Italy using a monoclonal immunocromatographic method and to estimate the prevalence of anti-Ca alloantibodies in Ca- horses using agglutination on gel technique. Ca blood type was determined on 110 whole blood samples. The prevalence of the Ca+ blood type was 79.1%. This study also provides data about the prevalence of Ca+ blood group in Italian Saddle Horses (77,3%) and Dutch Warmblood (58,3%). No significant association was found between Ca blood type and sex with 79.5% and 78.8% of females and males testing Ca+, respectively. The total number of Ca- samples with detectable anti-Ca alloantibodies was 7/23 (30.4%)

    Prevalence of Blood Types and Alloantibodies of the AB Blood Group System in Non-Pedigree Cats from Northern (Lombardy) and Southern (Sicily) Italy

    Get PDF
    The aims of this study were to determine the prevalence of A, B and AB blood types and alloantibodies in non-pedigree cats from two regions, one in Northern and one in Southern Italy (Lombardy and Sicily, respectively). A total of 448 samples (52.0% from Northern and 48.0% from Southern Italy) were blood typed. The prevalence of A, B and AB blood types in northern and southern cats were 91.0%, 5.2%, 3.8%, and 77.2%, 12.1% and 10.7%, respectively. The prevalence of type-A blood in southern cats was significantly lower (p = 0.0001) than in northern cats, while type-B and AB blood were significantly higher (p = 0.0085 and p = 0.0051, respectively) in Southern compared to Northern Italian cats. Alloantibodies against type-A blood were found in 94.1% of type-B cats, 11.2% of type-A cats had alloantibodies against type-B blood, while no type-AB cats had alloantibodies with no significant difference between the two Italian populations. Type-AB prevalence in non-pedigree cats in Southern Italy was the highest reported in Europe. Italian type-A cats had the lowest worldwide prevalence of alloantibodies against type-B blood. These results highlight the usefulness of regional studies to report different prevalences in feline blood types and reinforce the importance of blood typing cats before transfusions and mating

    Comparison of cross-matching method for detection of DEA 7 blood incompatibility

    Get PDF
    We compared 3 major cross-match (XM) tests to identify dog erythrocyte antigen (DEA) 7 blood incompatibilities in dogs as a result of anti\u2013DEA 7 antibodies: gel (GEL), standard tube (TUBE) agglutination, and immunochromatography strips (STRIP). Blood samples from 42 dogs were typed for DEA 7; 2 tested DEA 7\u2013positive (DEA 7+). The 40 DEA 7\u2013negative (DEA 7\u2013) plasma samples were cross-matched against the 2 DEA 7+ and 3 DEA 7\u2013 red blood cell (RBC) samples by GEL to identify samples with anti\u2013DEA 7 antibodies. Twenty DEA 7\u2013 plasma samples without and with anti\u2013DEA 7 antibodies were cross-matched with samples of the 2 DEA 7+ RBCs in a double-blind fashion using the TUBE and STRIP XM methods. GEL results were used as the reference method for comparison. To determine relationships between results, 2 7 2 tables were used. Cohen kappa coefficient (\u3ba) was calculated between results of GEL and the other 2 methods. With GEL, 21 of 40 XM tests were positive and 19 of 40 negative for anti\u2013DEA 7 antibodies. The same results were obtained by TUBE, whereas only 1 of 40 XM tests was positive by STRIP. There was a statistically significant relationship between results of GEL and TUBE (p < 0.000) with perfect agreement (\u3ba = 1.000), but not between GEL and STRIP results (p = 1.000) in which agreement was equivalent to chance (\u3ba = 0.0453). The GEL and TUBE XM tests, but not STRIP, are useful methods for identification of DEA 7 incompatibilities caused by anti\u2013DEA 7 antibodies
    • …
    corecore